RecruitingPhase 1 / Phase 2NCT05822908
Neurological
Spinocerebellar ataxia type 3
4
studies recruiting now
as of 7 Sept 2026
41
studies registered in total
as of 7 Sept 2026
9
countries with a recruiting site
as of 7 Sept 2026
21 Apr 2023
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT01060371
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
RecruitingNCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
RecruitingNCT00874783
Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Spinocerebellar ataxia type 3 studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Spinocerebellar ataxia type 3 study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Spinocerebellar ataxia type 3
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2/3Lithium Carbonate (Camcolit 250)
Phase 2Sodium Phenylbutyrate (Ambutyrate)
Phase 2Trehalose
Phase 2Varenicline
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).